1. Home
  2. AGX vs RNA Comparison

AGX vs RNA Comparison

Compare AGX & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Argan Inc.

AGX

Argan Inc.

HOLD

Current Price

$314.85

Market Cap

3.9B

ML Signal

HOLD

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$71.76

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGX
RNA
Founded
1961
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AGX
RNA
Price
$314.85
$71.76
Analyst Decision
Hold
Buy
Analyst Count
5
20
Target Price
$286.80
$69.26
AVG Volume (30 Days)
432.3K
2.9M
Earning Date
12-04-2025
11-10-2025
Dividend Yield
0.64%
N/A
EPS Growth
76.74
N/A
EPS
8.49
N/A
Revenue
$915,030,000.00
$20,868,000.00
Revenue This Year
$11.43
$64.11
Revenue Next Year
$18.27
$37.25
P/E Ratio
$36.93
N/A
Revenue Growth
13.49
106.27
52 Week Low
$101.02
$21.51
52 Week High
$399.30
$71.79

Technical Indicators

Market Signals
Indicator
AGX
RNA
Relative Strength Index (RSI) 42.92 77.56
Support Level $343.01 $71.42
Resistance Level $368.21 $71.76
Average True Range (ATR) 24.79 0.41
MACD -6.07 -0.73
Stochastic Oscillator 30.17 88.32

Price Performance

Historical Comparison
AGX
RNA

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

Share on Social Networks: